INTRODUCTION
Rheumatic mitral stenosis (RMS) being a complication of rheumatic fever (RF) has still been responsible for significant morbidity and mortality in developing countries even if this problem is steadily decreasing in developed countries [1] .
Percutaneous transluminal mitral valvuloplasty (PTMV) techniques and equipments have continued to evolve over the last two decades. With this expanded experience, there has been refinement in patient selection and a clearer understanding of the benefits, limitations, and long-term results of PTMV [2] . It has become the first choice of the treatment in symptomatic severe mitral stenosis and favorable valve morphology in the absence of left atrial thrombus or moderate-to-severe MR [2, 3] .
RMS is associated with autoimmune and inflammatory processes. The role of systemic inflammation in RMS has been documented [4, 5] . As an inflammatory marker, Neutrophil to lymphocyte ratio (NLR) has been shown many diseases and It has been reported that increased NLR associated with poor prognosis in many inflammatory diseases, malignancies, cardiovascular diseases, atrial fibrillation, and heart failure in literature [6, 7] . Increased NLR has recently been reported in RMS [8, 9] .
The association between PTMV and chronic inflammation in RMS has been reported in two limited study [10, 11] . In the present study, we aimed to investigate whether PTMV reduces the chronic systemic inflammatory response in patients with RMS.
METHODS

Study population
This study was conducted in a tertiary heart center between January 2009 and January 2014. A total of 41 consecutive patients with severe RMS undergoing successful PTMV and meeting eligibility criteria were included in the study. The exclusion criteria were acute coronary syndrome, decompensated heart failure, renal or hepatic failure, infectious diseases, autoimmune, inflammatory and connective tissue diseases, anemia (hemoglobin for women <12 g/dL and for men <13 g/dL) and other hematologic diseases, malignancy, chronic pulmonary diseases, substantial valvular heart disease other than mitral valvular disease, previous cardiac surgery.
The study was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. The study protocol was approved by the ethics committee of the institution and all patients were taken written informed consent for the participation.
Laboratory analysis
We used NLR, which is a simply available and inexpensive biomarker of systemic inflammatory response, to evaluate the level of inflammation. Laboratory assessments of all patients by the measuring of NLR before and one month after the PTMV procedure were performed. The blood samples were drawn from the antecubital veins after 8 hours fasting. EDTA tubes were used for complete blood counts. Complete blood counts were analyzed with a laser based automatic analyzer (Mindray BC 5800, China).
Echocardiography
Transthoracic echocardiographic examinations were performed by experienced physicians via Vivid S5 echocardiography system with 2.5 mHz transducer (GE-Vingmed Ultrasound AS, Horten, Norway) with standard methods according to the recommendations of the American Society of Echocardiography [12] . Ejection fraction was measured by modified Simpson's rule. Left atrial diameter (LAD) and left ventricular end-diastolic diameter (LVEDD) were measured in the parasternal long axis view with M-mode echocardiography technique. Mitral valve area was calculated with planimetric method in the parasternal short axis view at the tip of the mitral valve leaflets and the pressure half-time method with a continuous wave Doppler in apical 4-chamber view. The values were averaged. The peak and mean transmitral gradients were measured with the same method. Criteria for the diagnosis of RMS included MVA ≤2 cm2, the presence of commissural fusion, leaflet thickening, and the alteration of the subvalvular apparatus, documented by an echocardiogram [13] .
Statistical analysis
Statistical analyzes were performed using the SPSS software version 17.0 for Windows (SPSS Inc., Before and after the PTMV, the mean lymphocyte counts were found 2.1±0.6 x10.e3 /µL and 1.9±0.6 x10 3 / µL (p=0.01), and the mean leukocyte counts were 4.8±1.4 x10 3 /µL and 4.4±1.3 x10 3 / µL (p=0.069) respectively. NLR values were determined as 2.7 ± 1.0 and 2.2 ± 0.8, respectively, before and after the PTMV (Figure 1 ). After the PTMV, there was significant decrease in NLR in patients with RMS (p=0.001) ( Table 2 ). In the correlation analysis, there was significant positive correlation between left atrial diameter and NLR (p=0.028 r=0.344) and, there was significant negative correlation between the mitral valve area and NLR (p= 0.004-r=0.440) ( Table 3 and Figure 2 ). 
DISCUSSION
In this study, NLR, which is a simply available and inexpensive biomarker of systemic inflammatory response, were used to evaluate the level of inflammation. After the PTMV, there was significant decrease in NLR in patients with RMS, which means reduced inflammation after PTMV. There were significant correlations between NLR and the mitral valve area and left atrial diameter, also. In acute RF, there are inflammation and edema of the leaflets; it has been believed that the repeated episodes of the carditis associated with RF are responsible for chronic rheumatic valve disease, characterized by the deposition of fibrous tissue [4, 14] . On the other hand, the role of continuous inflammation has strongly been put forward by different studies of inflammation markers [4, [8] [9] [10] [11] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
Polat and Akboga et al have found that high NLR is associated with RMS and the severity of the stenosis [8, 9] . Rifae and Chen et al reported that high interleukin 6 levels and high CD 40 levels are associated with RMS [10, 11] . Golbasi, Atalar and Krasuski et al showed that high sensitive C-reactive protein levels are higher in patients with RMS and there is a role of ongoing chronic inflammation in RMS [4, 14, 15] . Akboga et al have recently pointed out that there is an association between red blood cell distribution width and the presence and the severity of RMS [16] . Chiu-Braga et al observed that significantly elevated levels of advanced oxidation protein products and high sensitive C-reactive protein were in patients with rheumatic valvular disease (RVD) [17] . Banerjee et al showed high levels of collagen metabolism markers in patients with RVD [18] . Pulimamidi et al presented that increased levels of markers of oxidative stress and inflammation in patients with RMS predispose to left atrial thrombus formation [19] . Caglı et al reported that plasma levels of tumor necrosis factor-alpha and soluble TNF receptor increase in RMS [20] . Mukherjee et al pointed out the role of the complement and coagulation cascade in RMS patients [21] . Recently, Ozturk et al reported that high NLR and ongoing inflammation is associated with the development of left atrial spontaneous echocardiographic contrast and thrombus formation [22] . Further evidence of ongoing inflammation in RMS is supported by other studies [23] .
However, there is no clear evidence about whether increased inflammation increases the severity of stenosis or increased stenosis raises the severity of inflammation. Ostovan et al reported that there is no association between high sensitive C-reactive protein levels and mitral valve restenosis after PTMV [24] . On the other hand, Rifaie et al suggested that chronic ongoing inflammation may have a role in the development of restenosis after PTMV in RMS [10] . Chen et al pointed out that PTMV reduces the inflammation in RMS patients [11] . Our result is consistent with this study and supports reduced inflammation after PTMV in RMS patients.
This study does have some limitations. Major limitations of the present study are small number of patients, single centered design, and that there is no information about the association between reste-nosis and inflammation after PTMV. Despite these limitations, it is of importance in terms of showing that NLR may be useful marker to show reduced inflammation after PTMV and to follow up the inflamatuar state after PTMV in RMS.
In conclusion, this study showed significant decrease in NLR after PTMV in patients with RMS, which means reduced inflammation after PTMV. Further studies are needed to confirm the results.
